Victor VogelVictor G. Vogel, MD, MHS is the Director of the Magee-Womens Hospital/University of Pittsburgh Cancer Institute Breast Cancer Prevention Program. He serves as the protocol chairman of the National Cancer Institute's STAR Trial (Study of Tamoxifen ad Raloxifene). Dr. Vogel is board-certified in internal medicine, medical oncology, and general preventive medicine/public health, and he is a fellow of the American Colleges of Medicine and Preventive Medicine. A University of Pittsburgh Professor of Medicine and Epidemiology, Dr. Vogel graduated from Temple University Medical School and earned his Master of Health Science degree from the Johns Hopkins University where he was an Andrew W. Mellon Fellow in Clinical Epidemiology. His research interests are in breast cancer risk assessment and prevention. He is the author of more than 150 articles, book chapters and abstracts, and he edited the book Management of Patients at High Risk for Breast Cancer (Blackwell Science 2001). Read More Read Less